Seeing is believing: A review of apheresis therapy in the treatment of ophthalmologic disease-Reference-Cited by-同舟云学术

Seeing is believing: A review of apheresis therapy in the treatment of ophthalmologic disease

Published:2017-11-18 Issue:3 Volume:33 Page:380-392
ISSN:0733-2459
Container-title:Journal of Clinical Apheresis
language:en
Short-container-title:J Clin Apher

Author:

Graham Brendan C.¹^ORCID,Pulido Jose S.²,Winters Jeffrey L.¹^ORCID

Affiliation:

1. Department of Laboratory Medicine and Pathology; Mayo Clinic; Rochester Minnesota

2. Department of Ophthalmology; Mayo Clinic; Rochester Minnesota

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jca.21607/fullpdf

Reference89 articles.

1. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue;Schwartz;J Clin Apher.,2016

2. Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange;Keegan;Lancet.,2005

3. Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica;Merle;Arch Ophthalmol.,2012

4. Current knowledge and trends in age-related macular degeneration: genetics, epidemiology, and prevention;Velez-Montoya;Retina.,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue;Journal of Clinical Apheresis;2023-04

2. Analysis of first apheresis services in Ghana-Greater Accra Regional Hospital;Heliyon;2022-11

3. Ocular Paraneoplastic Syndromes: A Critical Review of Diffuse Uveal Melanocytic Proliferation and Autoimmune Retinopathy;Cancer Control;2022-09

4. Nonparaneoplastic and Paraneoplastic Autoimmune Retinopathies;Albert and Jakobiec's Principles and Practice of Ophthalmology;2022

5. Sympathetic Ophthalmia: Where Do We Currently Stand on Treatment Strategies?;Clinical Ophthalmology;2021-10